Actively Recruiting
A Novel Intervention for Weight Loss in Young Adults
Led by University of Chicago · Updated on 2025-11-17
140
Participants Needed
1
Research Sites
207 weeks
Total Duration
On this page
Sponsors
U
University of Chicago
Lead Sponsor
N
Northwestern University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Obesity and cardiometabolic risks are significant public health issues, with about two-thirds of U.S. adults overweight or obese. Weight loss can prevent these health problems, but current lifestyle interventions have limited success. New, effective strategies are needed to address this rising issue at the population level. The goal of this clinical trial is to investigate how a behavioral intervention combined with technology impacts weight loss in young adults. The main questions it aims to answer are: • How does the combination of behavioral intervention and technology influence weight loss in young adults?
CONDITIONS
Official Title
A Novel Intervention for Weight Loss in Young Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Overweight or obese (BMI 25.5-34.9 kg/m2) men and women
- Ages 18 to 40 years
- Weight stable (no change >25 lbs in the past 3 months)
- Owns a smartphone and willing to install the study app
You will not qualify if you...
- Presence of obstructive sleep apnea or other sleep disorders
- Irregular menses, menopausal symptoms, post-menopausal, currently pregnant, trying to get pregnant or nursing
- Regular travel across time zones
- Currently following a weight loss regimen or special diet or exercise program
- Increased fractional lean body mass (e.g., athletes)
- Unable to walk, using an assistive device for mobility, or contraindications to exercise
- Diabetes
- Claustrophobia
- Excessive alcohol (>2 drinks/day), caffeine (>300mg/day) intake, regular nicotine use, or substance abuse
- Abnormal screening blood test results
- Taking prescription or over-the-counter drugs/supplements affecting sleep or weight
- Major psychiatric or eating disorders
- Acute or chronic medical conditions increasing intervention risks, including heart disease (unstable angina, recent hospitalization for heart failure, significant arrhythmias), pulmonary disease needing oxygen or bronchodilators, recent cancer treatment unless prognosis is good, active infections, thyroid/endocrine disorders, hepatitis or chronic gastrointestinal disease, renal disease, significant anemia
- Recent or significant abdominal surgery
- Acute coronary syndrome or stroke within past 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Chicago
Chicago, Illinois, United States, 60637
Actively Recruiting
Research Team
O
Olivia Hughes
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here